Filter zurücksetzen
Stichworte
HIV ×
Zeige mehr Stichworte
Inhaltsverzeichnis
  1. 1. Klinische Studie
  2. 2. Routinedokumentation
  3. 3. Register-/Kohortenstudien
  4. 4. Qualitätssicherung
  5. 5. Datenstandard
  6. 6. Patientenfragebogen
  7. 7. Medizinische Fachrichtung
Ausgewählte Datenmodelle

Sie müssen eingeloggt sein, um mehrere Datenmodelle auszuwählen und diese herunterzuladen oder zu analysieren.

140 Suchergebnisse.
Relevanz Bewertung Neue zuerst Alte zuerst

AMC-047 AIDS and Cancer Specimen Resource (ACSR) Procurement Form (F37)

- 29.08.17 - 1 Formular, 4 Itemgruppen, 14 Datenelemente, 1 Sprache
Itemgruppen: Header - AIDS and Cancer Specimen Resource (ACSR) Procurement Form, Specimen Procurement, Contact Information, Comments
AMC-047 AIDS and Cancer Specimen Resource (ACSR) Procurement Form (F37) Combination Chemotherapy and Rituximab in Treating Patients With Newly Diagnosed AIDS-Related B-Cell Non-Hodgkin's Lymphoma Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=21FA0742-63E9-07A9-E044-0003BA3F9857

AMC-047 HIV Viral Load Form (F40)

- 28.08.17 - 1 Formular, 3 Itemgruppen, 9 Datenelemente, 1 Sprache
Itemgruppen: Header - HIV Viral Load Form, HIV Viral Load, Comments
AMC-047 HIV Viral Load Form (F40) Combination Chemotherapy and Rituximab in Treating Patients With Newly Diagnosed AIDS-Related B-Cell Non-Hodgkin's Lymphoma Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=21FA0029-D088-0711-E044-0003BA3F9857

AMC-048 AIDS and Cancer Specimen Resource (ACSR) Procurement Form (F37)

- 28.08.17 - 1 Formular, 4 Itemgruppen, 14 Datenelemente, 1 Sprache
Itemgruppen: Header - AIDS and Cancer Specimen Resource (ACSR) Procurement Form, Specimen Procurement, Contact Information, Comments
AMC-048 AIDS and Cancer Specimen Resource (ACSR) Procurement Form (F37) Rituximab and Combination Chemotherapy in Treating Patients With Newly Diagnosed, HIV-Associated Burkitt's Lymphoma Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=32E18FA2-31A3-4AF2-E044-0003BA3F9857

AMC-048 HIV Viral Load Form (F40)

- 28.08.17 - 1 Formular, 3 Itemgruppen, 9 Datenelemente, 1 Sprache
Itemgruppen: Header - HIV Viral Load Form, HIV Viral Load, Comments
AMC-048 HIV Viral Load Form (F40) Rituximab and Combination Chemotherapy in Treating Patients With Newly Diagnosed, HIV-Associated Burkitt's Lymphoma Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=32E1BD21-3D3D-538C-E044-0003BA3F9857

AMC-047 HIV T-Cell Laboratory Values Form (F24)

- 28.08.17 - 1 Formular, 3 Itemgruppen, 11 Datenelemente, 1 Sprache
Itemgruppen: Header - HIV T-Cell Laboratory Values Form, T-Cell Laboratory Values, Comments
AMC-047 HIV T-Cell Laboratory Values Form (F24) Combination Chemotherapy and Rituximab in Treating Patients With Newly Diagnosed AIDS-Related B-Cell Non-Hodgkin's Lymphoma Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=21F8FABF-DDCE-0656-E044-0003BA3F9857

AMC-075 HIV T-Cell Laboratory Values Form (F24)

- 24.08.17 - 1 Formular, 2 Itemgruppen, 11 Datenelemente, 1 Sprache
Itemgruppen: Header - HIV T-Cell Laboratory Values Form, T-Cell Laboratory Values
AMC-075 HIV T-Cell Laboratory Values Form (F24) Vorinostat and Combination Chemotherapy With Rituximab in Treating Patients With Previously Untreated HIV-Related Diffuse Large B-Cell Non-Hodgkin Lymphoma Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=9F15665C-2E3D-498C-E040-BB89AD433080

Anal Cancer HIV Cisplatin, Fluorouracil, Cetuximab, and Radiation NCT00324415 AMC-045 - Anal Cancer Initial Evaluation Form

- 28.07.17 - 1 Formular, 4 Itemgruppen, 31 Datenelemente, 1 Sprache
Itemgruppen: Header Module, Tumor Characteristics, Procedures, TNM classification before treatment
AMC-045 Anal Cancer Initial Evaluation Form (IEF) NCT00324415 Pre-Study - AMC-045 Anal Cancer Initial Evaluation Form (IEF) - 2516530v1.0 Cisplatin, Fluorouracil, Cetuximab, and Radiation Therapy in Treating Patients With HIV and Stage I, Stage II, or Stage III Anal Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=1C146420-B4DA-57A0-E044-0003BA3F9857

HIV HPV Vaccine NCT00513526 AMC-052 - Screen Failure Predictor Variables Survey

- 19.07.17 - 1 Formular, 2 Itemgruppen, 11 Datenelemente, 1 Sprache
Itemgruppen: Verbal Consent, Viral load
Infection NCT00513526 Registration - AMC-052 Screen Failure Predictor Variables Survey Form - 2958715v1.0 AMC-052 Screen Failure Predictor Variables Survey Form Human Papillomavirus Vaccine Therapy in Treating Men With HIV-1 Infection Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=77B9D50C-53A6-8752-E040-BB89AD4320A2

HIV HPV vaccine NCT00513526 AMC-052 - High Resolution Anoscopy

- 19.07.17 - 1 Formular, 2 Itemgruppen, 19 Datenelemente, 1 Sprache
Itemgruppen: Digital rectal exam, Anoscopy
Infection NCT00513526 On-Study - AMC-052 High Resolution Anoscopy (HRA) Form - 2676571v1.0 AMC-052 High Resolution Anoscopy (HRA) Form Human Papillomavirus Vaccine Therapy in Treating Men With HIV-1 Infection Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=3950FE87-444E-42CA-E044-0003BA3F9857

Genetic Screening For HLA-B*5701 Pregnancy Notification Form NCT00340080

- 20.06.17 - 1 Formular, 2 Itemgruppen, 33 Datenelemente, 1 Sprache
Itemgruppen: Pregnancy Notification Form, Drug exposures
NCT00340080 / VIIV-CNA106030 https://clinicaltrials.gov/ct2/show/NCT00340080 A phase IV, randomised, multicentre, double-blind, study to evaluate the clinical utility of prospective genetic screening (HLA-B*5701) for susceptibility to abacavir hypersensitivity Assessment: Pregnancy Notification Form Medicine: abacavir, Condition: Infection, Human Immunodeficiency Virus, Phase: 4, Clinical Study ID: CNA106030, Sponsor: ViiV

Genetic Screening For HLA-B*5701 n Patients with HIV Day 1 NCT00340080 - Genetic Screening For HLA-B*5701 Day 1 NCT00340080

- 20.06.17 - 1 Formular, 1 Itemgruppe, 12 Datenelemente, 1 Sprache
Itemgruppe: Day 1
NCT00340080 / VIIV-CNA106030 https://clinicaltrials.gov/ct2/show/NCT00340080 A phase IV, randomised, multicentre, double-blind, study to evaluate the clinical utility of prospective genetic screening (HLA-B*5701) for susceptibility to abacavir hypersensitivity Assessment: Day 1 (Cohort Study) Medicine: abacavir, Condition: Infection, Human Immunodeficiency Virus, Phase: 4, Clinical Study ID: CNA106030, Sponsor: ViiV

Genetic Screening For HLA-B*5701 n Patients with HIV Week 1 NCT00340080 - Genetic Screening For HLA-B*5701 Week 1 NCT00340080

- 20.06.17 - 1 Formular, 1 Itemgruppe, 18 Datenelemente, 1 Sprache
Itemgruppe: Week 1
NCT00340080 / VIIV-CNA106030 https://clinicaltrials.gov/ct2/show/NCT00340080 A phase IV, randomised, multicentre, double-blind, study to evaluate the clinical utility of prospective genetic screening (HLA-B*5701) for susceptibility to abacavir hypersensitivity Assessment: Week 1 Medicine: abacavir, Condition: Infection, Human Immunodeficiency Virus, Phase: 4, Clinical Study ID: CNA106030, Sponsor: ViiV

Kontakt

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Hilfe

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video